Download video

Differences in approaches to managing patients with multiple myeloma vs amyloidosis

133 views

VJHemOnc – Video Journal of Hematology & HemOnc

10 days ago

Differences in approaches to managing patients with multiple myeloma vs amyloidosis

Differences in approaches to managing patients with multiple myeloma vs amyloidosis

Spot The Difference 272
6:08
Spot The Difference 272
by Brain trainingCH
Q2
7:01
Q2
by HoungJunHongBiology
C9orf72 repeat expansions disrupt microglial function in ALS
6:30
C9orf72 repeat expansions disrupt microglial function in ALS
by AI x biology
Liver – Focal Nodular Hyperplasia – Isoechoic – Clip 2 B-mode + Color + microV
1:24
Liver – Focal Nodular Hyperplasia – Isoechoic – Clip 2 B-mode + Color + microV
by SonoVerse – Visual Ultrasound Glossary
Video 242: Gastroschisis. 12w fetus
0:33
Video 242: Gastroschisis. 12w fetus
by Bs Đăng Hùng
Anaplastic Gliomas Evidence
26:39
Anaplastic Gliomas Evidence
by Rad Onc Talks
PL03.2 - All by All of Us: common and rare variant association testing in 250,000 whole genomes...
16:55
PL03.2 - All by All of Us: common and rare variant association testing in 250,000 whole genomes...
by European Society of Human Genetics
CNS E01: Modern Glioma Classification and Anaplastic Oligodendroglioma
21:57
CNS E01: Modern Glioma Classification and Anaplastic Oligodendroglioma
by Radonc smartlearn
Debate 2, Part 2 - KDIGO B Cell Controversies Conference Plenary
6:57
Debate 2, Part 2 - KDIGO B Cell Controversies Conference Plenary
by KDIGO
Enfortumab vedotin in combination with pembrolizumab shows improved survival rates in la\/mUC
6:16
Enfortumab vedotin in combination with pembrolizumab shows improved survival rates in la\/mUC
by ecancer
C3.2 Defence Against Disease [IB Biology SL\/HL]
16:35
C3.2 Defence Against Disease [IB Biology SL\/HL]
by Sirius Revision
Does the relative dose intensity of bispecific antibodies matter in patients with multiple myeloma?
5:14
Does the relative dose intensity of bispecific antibodies matter in patients with multiple myeloma?
by VJHemOnc – Video Journal of Hematology \& HemOnc
Interim analysis of the ELM-2 study: odronextamab in patients with R\/R follicular lymphoma
2:43
Interim analysis of the ELM-2 study: odronextamab in patients with R\/R follicular lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
RELATIVITY-020: dose comparison of nivolumab and relatlimab in melanoma
3:08
RELATIVITY-020: dose comparison of nivolumab and relatlimab in melanoma
by VJOncology
MAIC of epcoritamab with R-squared versus tafasitamab with R-squared in 2L+ follicular lymphoma
1:28
MAIC of epcoritamab with R-squared versus tafasitamab with R-squared in 2L+ follicular lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
1:10
TU2218, a TGFβ-RI and VEGFR2 dual inhibitor, with pembrolizumab in solid tumors
by VJOncology
Part 2\/5: Considerations For Designing Immunohistochemical Procedures: Selecting your reagents
21:08
Part 2\/5: Considerations For Designing Immunohistochemical Procedures: Selecting your reagents
by Vector Laboratories Inc